It is commonly investigated as a long-acting amylin analogue, sometimes used in combination with other metabolic agents
Potential side effects may include injection-site redness, swelling, bruising, itching, tenderness, small lumps, headache, fatigue, nausea, appetite changes, abdominal discomfort, stool changes, dizziness, altered sleep, mood changes, or feeling off. Allergic or immune reactions are also possible, and the FDA has specifically raised concerns about immunogenicity and peptide-related impurities in compounded BPC-157
Avoid freeze-thaw cycles they are one of the most common causes of activity loss
~ AlphaMD You've been crushing it at the gym
2.7 Network pharmacology Compound information was obtained through PubChem